Zu den Deals
Gesundheitswesen

Iason GmbH has continued its refinancing efforts with local banks based on an IBR

The shareholders of Iason GmbH have completed a restructuring of the company and its refinancing efforts with local banks based on an IBR.

The Iason group produces radiopharmaceuticals and supplies special laboratory products to the target group "nuclear medicine" and "laboratory medicine" providing innovative products with the highest quality standards. The company has customers from all over Europe.

Oaklins' team in Austria assisted Iason with the preparation of the IBR (independent business review) and negotiations with local banks regarding refinancing possibilities.

Sprechen Sie mit dem Deal-Team

Thomas Jungreithmeir

Geschäftsführender Partner
Wien, Österreich
Oaklins Austria

Relevante Transaktionen

Bayer AG has entered into a takeover agreement with Cara Care
Gesundheitswesen | Technologie, Medien und Telekommunikation

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Weitere Informationen
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Gesundheitswesen

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Weitere Informationen
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Gesundheitswesen

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Weitere Informationen